INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 15, 2021 |
Director, President and Chief Scientific
Trans History: 598
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 14,000 | -- | -- |
| Apr 15, 2021 |
Director, President and Chief Scientific
Trans History: 598
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 5,383 | -- | -- |
| Apr 15, 2021 |
Director, President and Chief Scientific
Trans History: 598
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 5,383 | -- | 5,383 |
| Apr 01, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 446 | -- | 142,350 |
| Feb 25, 2021 |
EVP Research and Development
Trans History: 634
|
EVP Research and Development | Form 4 | Bona fide gift | 435 | -- | 24,280 |
| Jan 19, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 414 | -- | 142,796 |
| Jan 12, 2021 |
Director, President and Chief Scientific
Trans History: 598
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 82,108 | -- | 82,108 |
| Nov 19, 2020 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 2,406 | -- | 47,786 |
| Nov 19, 2020 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 2,406 | -- | 3,609 |
| Oct 06, 2020 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 349 | -- | 143,210 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.